Search

everythinglearnresearchcommunity

for

Search:↓

Hair levels of estradiol and progesterone are higher in premenopausal than postmenopausal women, but the difference isn't statistically significant, indicating the need for a better measurement method.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Finasteride with oral contraceptive improves hair loss in 62% of premenopausal women.

The study found that a specific type of hair loss is increasingly common in premenopausal women and can be effectively diagnosed and treated with various medications.

Oral finasteride, combined with drospirenone, improved hair loss in 62% of premenopausal women, with no reported side effects.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Experts made a guide to help doctors evaluate women with too much hair growth.

Low estrogen compared to androgen may cause female hair loss.

Patterned hair loss is relatively common in women and not usually a sign of serious health issues.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

FFA in young women is often missed, and no single treatment works best.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.

The Fatty Liver Index (FLI) may not be enough to rule out non-alcoholic fatty liver disease in lean women with polycystic ovary syndrome.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

Isotretinoin may cause temporary, reversible facial hair growth in some women.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Low iron, low thyroid function, and stress are linked to excessive hair shedding in women.

Spironolactone helps reduce hair growth in women with hirsutism but may cause menstrual irregularities.

Female pattern hair loss severity is linked to physical signs of high androgens, not blood hormone levels.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.